Science Explorer Back to mapMap
Discussion
Company · Mainz · Germany

BioNTech (Germany)

biontech.deROR OpenAlex
World rank, 2022-now
#8,743
of 22,385 · #6,071 all time
Rank in Germany
#289
of 795
Research works
243
▲ 71% vs 2018-21
Citations
11k
47.1 per fractional work
Top-10% rate
18.4%
all institutions 10.0%
vs its own fields
1.13×
1.00× is exactly expected
Open access
63%
world 40%
International
50%
world 18%
BioNTech (Germany)

Which fields of science does BioNTech (Germany) work in?

In 2022-now, 46% of research at BioNTech (Germany) is in Health Sciences, 39% in Life Sciences. Its largest fields are Medicine (45%), Biochemistry, Genetics and Molecular Biology (24%), Immunology and Microbiology (11%). It does 2.7× the world's share of Life Sciences.

Health Sciences: 56 fractional works · 45.8% of its workMedicine: 55 fractional works · 45.4% of its workOncology: 17 fractional works · 14.0% of its workInfectious Diseases: 14 fractional works · 11.7% of its workRadiology, Nuclear Medicine and Imaging: 7 fractional works · 5.5% of its workPulmonary and Respiratory Medicine: 3 fractional works · 2.6% of its workSurgery: 3 fractional works · 2.2% of its workEpidemiology: 2 fractional works · 2.1% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 1.0% of its workNeurology: 1 fractional works · 0.9% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 0.9% of its workGenetics: 1 fractional works · 0.7% of its workHematology: 1 fractional works · 0.5% of its workPhysiology: 1 fractional works · 0.5% of its workRheumatology: 0 fractional works · 0.4% of its workHepatology: 0 fractional works · 0.3% of its workObstetrics and Gynecology: 0 fractional works · 0.3% of its workPsychiatry and Mental health: 0 fractional works · 0.3% of its workPathology and Forensic Medicine: 0 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 1.2% of its workHealth Professions: 0 fractional works · 0.3% of its workGeneral Health Professions: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.0% of its workNursing: 0 fractional works · 0.1% of its workDentistry: 0 fractional works · 0.0% of its workLife Sciences: 48 fractional works · 39.2% of its workBiochemistry, Genetics and Molecular Biology: 29 fractional works · 24.0% of its workMolecular Biology: 20 fractional works · 16.2% of its workGenetics: 4 fractional works · 3.6% of its workCancer Research: 2 fractional works · 1.7% of its workBiotechnology: 2 fractional works · 1.5% of its workPhysiology: 0 fractional works · 0.4% of its workMolecular Medicine: 0 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 0.5% of its workImmunology and Microbiology: 14 fractional works · 11.5% of its workImmunology: 12 fractional works · 10.2% of its workVirology: 1 fractional works · 0.7% of its workMicrobiology: 1 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workAgricultural and Biological Sciences: 3 fractional works · 2.1% of its workAnimal Science and Zoology: 2 fractional works · 1.4% of its workPlant Science: 1 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 1.1% of its workPharmacology: 1 fractional works · 0.4% of its workPharmaceutical Science: 0 fractional works · 0.4% of its workToxicology: 0 fractional works · 0.3% of its workNeuroscience: 1 fractional works · 0.4% of its workNeurology: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.0% of its workPhysical Sciences: 13 fractional works · 10.7% of its workEngineering: 4 fractional works · 3.1% of its workElectrical and Electronic Engineering: 1 fractional works · 1.2% of its workIndustrial and Manufacturing Engineering: 1 fractional works · 0.8% of its workBiomedical Engineering: 1 fractional works · 0.8% of its workSmaller subfields together: 0 fractional works · 0.3% of its workComputer Science: 2 fractional works · 2.0% of its workArtificial Intelligence: 2 fractional works · 1.5% of its workComputer Vision and Pattern Recognition: 1 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.0% of its workEnvironmental Science: 2 fractional works · 1.7% of its workPollution: 1 fractional works · 0.6% of its workEcology: 1 fractional works · 0.5% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workMaterials Science: 2 fractional works · 1.5% of its workBiomaterials: 1 fractional works · 0.9% of its workMaterials Chemistry: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.3% of its workMathematics: 2 fractional works · 1.4% of its workStatistics and Probability: 1 fractional works · 1.1% of its workModeling and Simulation: 0 fractional works · 0.2% of its workChemistry: 1 fractional works · 0.7% of its workPhysical and Theoretical Chemistry: 0 fractional works · 0.3% of its workOrganic Chemistry: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPhysics and Astronomy: 0 fractional works · 0.2% of its workChemical Engineering: 0 fractional works · 0.1% of its workEnergy: 0 fractional works · 0.1% of its workEarth and Planetary Sciences: 0 fractional works · 0.0% of its workSocial Sciences: 5 fractional works · 4.4% of its workSocial Sciences: 3 fractional works · 2.5% of its workHealth: 3 fractional works · 2.1% of its workCommunication: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.0% of its workDecision Sciences: 1 fractional works · 1.0% of its workStatistics, Probability and Uncertainty: 1 fractional works · 0.8% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.4% of its workEconomics and Econometrics: 0 fractional works · 0.4% of its workBusiness, Management and Accounting: 0 fractional works · 0.3% of its workPsychology: 0 fractional works · 0.2% of its workALL ITS WORKBioNTech(Germany)122fractional works, 2022-now
Life Sciences39%Physical Sciences11%Health Sciences46%Social Sciences4%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 24 fields, with their numbers
    1. Medicine5545.4%
    2. Health Professions00.3%
    3. Nursing00.1%
    4. Dentistry00.0%
    1. Biochemistry, Genetics and Molecular Biology2924.0%
    2. Immunology and Microbiology1411.5%
    3. Agricultural and Biological Sciences32.1%
    4. Pharmacology, Toxicology and Pharmaceutics11.1%
    5. Neuroscience10.4%
    1. Engineering43.1%
    2. Computer Science22.0%
    3. Environmental Science21.7%
    4. Materials Science21.5%
    5. Mathematics21.4%
    6. Chemistry10.7%
    7. Physics and Astronomy00.2%
    8. Chemical Engineering00.1%
    9. Energy00.1%
    10. Earth and Planetary Sciences00.0%
    1. Social Sciences32.5%
    2. Decision Sciences11.0%
    3. Economics, Econometrics and Finance00.4%
    4. Business, Management and Accounting00.3%
    5. Psychology00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.45× its world share, 3 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.51× its world share, 29 worksBiochemistry, Geneti…Immunology and Microbiology: 11.40× its world share, 14 worksImmunology and Micro…Neuroscience: 0.26× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 3.10× its world share, 1 worksPharmacology, Toxico…Chemical Engineering: 0.35× its world share, 0 worksChemical EngineeringChemistry: 0.44× its world share, 1 worksChemistryComputer Science: 0.26× its world share, 2 worksComputer ScienceEarth and Planetary Sciences: 0.01× its world share, 0 worksEarth and Planetary …Energy: 0.07× its world share, 0 worksEnergyEngineering: 0.21× its world share, 4 worksEngineeringEnvironmental Science: 0.34× its world share, 2 worksEnvironmental ScienceMaterials Science: 0.43× its world share, 2 worksMaterials ScienceMathematics: 1.15× its world share, 2 worksMathematicsPhysics and Astronomy: 0.07× its world share, 0 worksPhysics and AstronomyDentistry: 0.09× its world share, 0 worksDentistryHealth Professions: 0.10× its world share, 0 worksHealth ProfessionsMedicine: 2.36× its world share, 55 worksMedicineNursing: 0.19× its world share, 0 worksNursingBusiness, Management and Accounting: 0.08× its world share, 0 worksBusiness, Management…Decision Sciences: 1.03× its world share, 1 worksDecision SciencesEconomics, Econometrics and Finance: 0.19× its world share, 0 worksEconomics, Econometr…Psychology: 0.06× its world share, 0 worksPsychologySocial Sciences: 0.20× its world share, 3 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 11.4×. Every wedge is a field page.

All 24 fields, with their numbers
  1. Immunology and Microbiology11.40×14 works
  2. Biochemistry, Genetics and Molecular Biology4.51×29 works
  3. Pharmacology, Toxicology and Pharmaceutics3.10×1 works
  4. Medicine2.36×55 works
  5. Mathematics1.15×2 works
  6. Decision Sciences1.03×1 works
  7. Agricultural and Biological Sciences0.45×3 works
  8. Chemistry0.44×1 works
  9. Materials Science0.43×2 works
  10. Chemical Engineering0.35×0 works
  11. Environmental Science0.34×2 works
  12. Neuroscience0.26×0 works
  13. Computer Science0.26×2 works
  14. Engineering0.21×4 works
  15. Social Sciences0.20×3 works
  16. Nursing0.19×0 works
  17. Economics, Econometrics and Finance0.19×0 works
  18. Health Professions0.10×0 works
  19. Dentistry0.09×0 works
  20. Business, Management and Accounting0.08×0 works
  21. Energy0.07×0 works
  22. Physics and Astronomy0.07×0 works
  23. Psychology0.06×0 works
  24. Earth and Planetary Sciences0.01×0 works

Who are the top researchers at BioNTech (Germany)?

Ranked on the quality score, Uğur Şahin, Alexander Muik and Mathias Vormehr lead among researchers whose main affiliation is BioNTech (Germany).

  1. 1 Uğur Şahin Germany · #14,452 worldwide 73k citations · 746 works
  2. 2 Alexander Muik Germany · #47,869 worldwide 8.9k citations · 119 works
  3. 3 Mathias Vormehr Germany · #141,243 worldwide 13k citations · 84 works
  4. 4 Annette B. Vogel Germany · #177,297 worldwide 3.4k citations · 40 works
  5. 5 Lena M. Kranz Germany · #273,491 worldwide 9.1k citations · 73 works
  6. 6 Andreas N. Kuhn Germany · #324,194 worldwide 9.8k citations · 81 works
  7. 7 Eleni Lagkadinou Germany · #343,206 worldwide 2k citations · 59 works
  8. 8 Karim Beguir Germany · #399,681 worldwide 1.2k citations · 46 works
  9. 9 Aras Toker Germany · #416,665 worldwide 1.1k citations · 67 works
  10. 10 Isabel Vogler Germany · #442,451 worldwide 8.1k citations · 33 works
All ranked researchers at BioNTech (Germany)

What are the most cited papers from BioNTech (Germany)?

The most cited paper from BioNTech (Germany) is "Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer" (Uğur Şahin et al., 2017), with 2,536 citations. Next come "mRNA-based therapeutics — developing a new class of drugs" (2,505) and "COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses" (2,072).

Most cited papers
#PaperReleasedCitations
1 Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer Uğur Şahin et al. · Nature 4 Jul 2017 2,536
2 mRNA-based therapeutics — developing a new class of drugs Uğur Şahin, Katalin Karikó, Özlem Türeci · Nature Reviews Drug Discovery ReviewOpen access 19 Sep 2014 2,505
3 COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses Uğur Şahin et al. · Nature Open access 30 Sep 2020 2,072
4 Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy Lena M. Kranz et al. · Nature Jun 2016 1,784
5 Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults Mark J. Mulligan et al. · Nature Open access 12 Aug 2020 1,598
All 61 most cited papers, with filters and sorting

Which keywords describe research at BioNTech (Germany)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Immunity, Vaccine, SARS-CoV-2, Cancer Immunotherapy, Pandemic, Coronavirus, ACE2 Receptor and Immunotherapy.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Immunity15▲ 31×5 topics
  2. Vaccine14▲ 29×9 topics
  3. SARS-CoV-212▲ 31×5 topics
  4. Cancer Immunotherapy12▲ 62×2 topics
  5. Pandemic11▲ 9.3×5 topics
  6. Coronavirus10▲ 42×2 topics
  7. ACE2 Receptor10▲ 37×2 topics
  8. Epidemiology10▲ 2.0×33 topics
  9. Immunotherapy10▲ 11×12 topics
  10. Gene Therapy10▲ 40×5 topics
  11. Antigen Presentation9▲ 83×2 topics
  12. Viral Transmission9▲ 54×2 topics
  13. Mutation9▲ 40×2 topics
  14. antibody9▲ 72×1 topic
  15. spike protein9▲ 72×1 topic
  16. Innate Immunity7▲ 19×7 topics
  17. Tumor Microenvironment7▲ 13×6 topics
  18. Tumor Regression7▲ 53×2 topics
  19. Immune Response6▲ 9.3×12 topics
  20. Pathogenesis6▲ 9.7×13 topics
  21. Dendritic Cells6▲ 56×1 topic
  22. Monoclonal Antibodies6▲ 55×3 topics
  23. Tumor Antigen6▲ 82×1 topic
  24. Immune Checkpoint Blockade6▲ 41×1 topic
  25. PD-1 and PD-L16▲ 41×1 topic
  26. Lymphoma6▲ 29×2 topics
  27. CAR T Cells6▲ 62×1 topic
  28. Chimeric Antigen Receptor6▲ 62×1 topic
  29. Chemotherapy5▲ 6.1×14 topics
  30. Glycosylation5▲ 37×3 topics
  31. Therapeutic Antibodies5▲ 57×2 topics
  32. Gene Silencing5▲ 41×2 topics
  33. RNA Interference5▲ 46×1 topic
  34. siRNA Delivery5▲ 66×1 topic
  35. Antibody Engineering4▲ 65×1 topic
  36. Fc Receptors4▲ 65×1 topic
  37. Targeted Therapy4▲ 15×4 topics
  38. Clinical Trials4▲ 4.6×7 topics
  39. Epitope Prediction3▲ 84×1 topic
  40. Peptide-MHC Binding3▲ 84×1 topic

Which research topics does BioNTech (Germany) publish most on?

By volume in 2022-now: SARS-CoV-2 and COVID-19 Research, Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers and CAR-T cell therapy research.

SARS-CoV-2 and COVID-19 Research: 9 fractional worksImmunotherapy and Immune Responses: 6 fractional worksCancer Immunotherapy and…6Cancer Immunotherapy and Biomarkers: 6 fractional worksCAR-T cell therapy resea…6CAR-T cell therapy research: 6 fractional worksRNA Interference and Gene Delivery: 5 fractional worksMonoclonal and Polyclonal Antibodies Research: 4 fractional worksvaccines and immunoinfor…3vaccines and immunoinformatics approaches: 3 fractional worksVirus-based gene therapy research: 3 fractional worksVaccine Coverage and Hesitancy: 2 fractional worksViral gastroenteritis research and epidemiology: 2 fractional works
Infectious DiseasesImmunologyOncologyMolecular Biology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 SARS-CoV-2 and COVID-19 Research Infectious Diseases 9 works
  2. 2 Immunotherapy and Immune Responses Immunology 6 works
  3. 3 Cancer Immunotherapy and Biomarkers Oncology 6 works
  4. 4 CAR-T cell therapy research Oncology 6 works
  5. 5 RNA Interference and Gene Delivery Molecular Biology 5 works
  6. 6 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 4 works
  7. 7 vaccines and immunoinformatics approaches Molecular Biology 3 works
  8. 8 Virus-based gene therapy research Genetics 3 works
  9. 9 Vaccine Coverage and Hesitancy Health 2 works
  10. 10 Viral gastroenteritis research and epidemiology Infectious Diseases 2 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available63.2%not open36.8%

World: 40% of research is openly available.

with international co-authors50.1%domestic only49.9%

World: 18% is written across borders.

How has BioNTech (Germany)'s research output changed?

Output in 2022-2025 was 71% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is BioNTech (Germany) as a percentage of every work published that year, 0.00055% in 2024.

still counting0.00020%0.00040%0.00060%BioNTech (Germany)0.00043% in 20251990200020102020

Fractional works of BioNTech (Germany) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Mainz

All research institutions in Mainz

Share BioNTech (Germany)'s ranking

BioNTech (Germany) on Science Explorer

A card with BioNTech (Germany)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about BioNTech (Germany). Posts are plain text and can be reported.